CION Cancer Clinics
Bridging therapy while waiting for a liver transplant | CION Cancer Clinics
Bridging therapy is treatment given to a liver cancer while you wait for a transplant, so the tumour does not grow beyond the limits the transplant team has set. TACE and ablation are the usual choices, picked by the tumour, the strength of the liver and the likely wait. This page explains how the choice is made, who it does not suit, and what it cannot change. At CION Cancer Clinics, a multidisciplinary tumour board weighs your liver function and your scans before recommending any treatment.
On this page
- What is bridging therapy before a liver transplant?
- What does the team weigh before choosing a bridge?
- What happens while you are on bridging therapy?
- Which treatments are used as a bridge to transplant?
- Who does bridging therapy not suit?
- What this page cannot tell you
- Common questions about bridging therapy
The short answer
What is bridging therapy before a liver transplant?
Bridging therapy is treatment given to a liver cancer while you wait for a transplant, to stop the tumour growing past the limits the transplant team has set. It is for people with primary liver cancer (hepatocellular carcinoma, or HCC) who have already been accepted, or are being assessed, for a transplant. It does not replace the transplant. It protects your place on the path towards it.
Why waiting is the problem
A transplant is offered for liver cancer only when the tumour is small and limited to the liver. The waiting can be long, especially for a deceased donor organ. During that time the cancer can grow, and if it grows beyond the agreed limits, the transplant may no longer be possible. Bridging treatment tries to hold it still.
Who this page is not about
If the cancer in your liver spread there from the bowel, breast or another organ, transplant is very rarely part of the plan, and this page does not apply. Read about primary and secondary liver cancer first. If the tumour is currently too large for a transplant and the aim is to shrink it into range, that is downstaging, which is a related but different goal.
How the choice is made
What does the team weigh before choosing a bridge?
No single bridge suits everyone. The tumour board looks at three things together, and the liver often decides more than the cancer does.
The tumour
How many spots there are, how big, and where they sit. A single small tumour away from large blood vessels may be treated directly. Several tumours, or one close to a major vessel, usually point towards a treatment given through the blood supply.
The liver
Most people waiting for a transplant have cirrhosis. Any bridge that strains a weak liver can tip it into failure and make the person too unwell for the operation.
Usually checked
- Child-Pugh and MELD scores, which grade liver function
- Bilirubin, the yellow pigment that rises in jaundice
- Fluid in the abdomen (ascites)
The expected wait
If a living donor transplant is likely soon, the team may watch closely without treating. If the wait is uncertain, as it often is for a deceased donor organ, bridging becomes more important.
Your general fitness
Heart, lungs, kidneys and nutrition all matter. A bridge should leave you at least as fit for the transplant as you were before it.
Not sure whether this applies to you?
Ask an oncologistStep by step
What happens while you are on bridging therapy?
The plan is agreed with the transplant centre
The CION tumour board reviews your scans and blood tests, and the plan is agreed with the licensed transplant centre that will carry out the operation, so both teams work towards the same target.
The bridge is given
Most bridges are procedures such as TACE or ablation, which CION coordinates through accredited partner hospitals. You are usually home within a short stay.
A scan checks the response
A contrast CT or MRI some weeks later shows whether the treated area has stopped taking up blood. That is the sign the tumour is no longer active.
Scans repeat while you wait
Regular scans continue for as long as you are on the list, because new spots can appear elsewhere in a cirrhotic liver. The bridge may be repeated if needed. Read more on surveillance on the waiting list.
Side by side
Which treatments are used as a bridge to transplant?
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Not for everyone
Who does bridging therapy not suit?
A bridge is only worth giving if it is safer than waiting. For some people it is not, and an honest team will say so.
When the liver is too weak
If liver function is already very poor, even a careful TACE can push the liver into failure. In that situation the team may decide that close watching, and moving quickly to transplant if an organ becomes available, carries less risk. Read about liver failure after TACE.
When immunotherapy is being considered
Immunotherapy wakes up the immune system, and a strong immune system can attack a new liver. Transplant teams approach it with great caution before an operation, and most avoid it close to a transplant. This is a decision for the transplant centre and your oncologist together.
When the cancer has already outgrown the limits
If scans show spread outside the liver or into the main blood vessels, bridging no longer leads to a transplant. The aim then shifts to other treatment, and that conversation should happen openly rather than through repeated procedures that change nothing.
Bridging treatment does not move anyone up a transplant waiting list, and no doctor or clinic can arrange that. Organ allocation follows rules set by the state programme, called Jeevandan in Telangana as of 2026, and those rules change, so check them with your transplant centre.
Being straight with you
What this page cannot tell you
It cannot tell you whether you need a bridge, which one, or when. That depends on your scans, your blood results and the likely wait, and only the team looking at all three together can answer it. Two people with tumours that look alike on paper can be given different advice because their livers are different.
It cannot predict the waiting time
How long you wait depends on your blood group, your liver scores, the rules of the allocation programme and whether a living donor is possible. None of those can be read from a web page. Ask the transplant coordinator directly, and ask again as things change.
The evidence has gaps
Bridging is widely used and makes sense, but the studies comparing one bridge with another are small. Much of the choice rests on the experience of the teams involved. That is a good reason to ask why a particular bridge was chosen for you.
If you have been told you are on a transplant list and nobody has discussed bridging, it is a fair question to raise at your next visit.Questions we are asked
Common questions about bridging therapy
Is bridging therapy the same as downstaging?
No. Bridging is for someone already within the transplant limits, to keep them there while they wait. Downstaging is for someone currently outside the limits, to shrink the tumour into range. The same procedures are often used for both, which is why the words get mixed up.
Does everyone on the list need a bridge?
No. Someone with a very small tumour and a living donor ready may simply be watched with regular scans. Bridging is more likely when the expected wait is long or uncertain. The decision is made case by case with the transplant centre.
Will the bridge make the transplant harder?
Usually not. TACE and ablation are routinely given before transplant. The main concern is the liver itself, because a procedure that weakens a cirrhotic liver can make you less fit for the operation. That is why liver function is checked before and after every treatment.
Can CION speed up my place on the waiting list?
No. Nobody can. Deceased donor organs are allocated by the state programme according to its own rules. What CION can do is plan cancer treatment that keeps you eligible, coordinate with your transplant centre and keep your scans and records in order.
What if the tumour grows despite the bridge?
The team may repeat the treatment or switch to a different one. If the cancer grows beyond the limits, the transplant centre may pause or end the listing. That is hard news, and treatment does not stop there. Other options are discussed openly.
Is a bridge needed before a living donor transplant?
Sometimes. Living donor assessment takes time too, for both people. If that process is likely to take a while, a bridge may still be used. Any donor decision belongs to the donor and the transplant centre, and the donor's own risks must be explained to them fully.
How is the cost of bridging handled?
Each procedure is billed separately from the transplant, and the total depends on which bridge is used and how often. Ask for a written, itemised estimate. Scheme and insurance cover differ by procedure, so the team can help you check what applies at the time.
Can I get a second opinion on the bridging plan?
Yes, and it does not offend a good team. Bring all your scans on disc, the reports and recent blood tests. Call the CION helpline and the tumour board can review the plan alongside your transplant centre's advice.
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Surgery for Liver Cancer
- American Cancer Society — Embolization Therapy for Liver Cancer
- NIDDK — Liver Transplant - NIDDK
- National Cancer Institute — Liver Cancer Treatment
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
On a transplant list and unsure about bridging?
Send us your scans and reports, and the tumour board will review whether a bridge makes sense for you, alongside your transplant centre's advice. One helpline serves every CION centre.